neuroscience-2017-scientifictracks-abstracts

2 / 14

Page 17
Notes:
conferenceseries.com
Volume 8, Issue 6 J Neurol Neurosci
ISSN: 2171-6625 Neuro, an open access journal Neuroscience 2017
October 16-17, 2017
OCTOBER 16-17, 2017 OSAKA, JAPAN
17TH Global Neuroscience Conference
A miracle (miR-196a) in the fight against Huntington’s disease
Shang-Hsun Yang and Chang ChihYi
National Cheng Kung University, Taiwan
Huntington’s Disease (HD) is a genetic disease and caused by a mutation in Huntingtin gene, leading to neuro-pathological
symptoms. To date, there is no effective medicine for HD. Based on previous studies, transcriptional regulation is
impaired during the progression of HD, and regulation of microRNA (miRNA) is one of affected mechanisms. Since HD leads
to dysfunction of gene regulation and one miRNA could target to multiple pathways, it suggests miRNA could be one potential
treatment for HD. In my laboratory, we identified one potential miRNA, miR-196a, from HD transgenic monkeys and found
the neuro-protective effects of miR-196a on HD in cell, transgenic mouse and HD patient-derived induced pluripotent stem
cell models. miR-196a could not only improve molecular, neuro-pathological and behavioral phenotypes in transgenic mouse
models, but also suppress pathological aggregates in neurons derived from HD patients. Furthermore, we also investigate
molecular mechanisms of miR-196a and show miR-196a could enhance cellular morphology, intracellular transport, synaptic
plasticity, neuronal activity, learning and memory both in vitro and in vivo. In addition, miR-196a could work through binding
to 3’ untranslated region of RAN binding protein 10 (RANBP10) to suppress the protein expression, further enhancing
the assembly of β-tubulin. Most importantly, overexpression of RANBP10 led to worse neuronal morphology and severer
pathological phenotypes in the HD transgenic mouse model, suggesting that miR-196a enhances neuronal morphology
through suppressing RANBP10 to provide neuro-protection in HD. These results suggest the important role of miR-196a on
HD and might provide a new insight of therapeutic strategy for HD.
Biography
Shang-Hsun Yang is an Associate Professor in Department of Physiology at National Cheng Kung University, Taiwan. He has completed his BSc at National Chung
Hsing University in 1998, MSc at National Taiwan University in 2000 and PhD at Emory University, USA, in 2008. His research interests focus on the regulation of
microRNAs on HD.
Shang-Hsun Yang et al., J Neurol Neurosci 2017, 8:6
DOI: 10.21767/2171-6625-C1-005